{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:19:50Z","timestamp":1763036390889,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1053\/j.ajkd.2009.02.015","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T04:25:06Z","timestamp":1240201506000},"page":"726-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Endothelin Receptor Antagonism and Renin Inhibition as Treatment Options for Scleroderma Kidney"],"prefix":"10.1053","volume":"54","author":[{"given":"Neeraj","family":"Dhaun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain M.","family":"MacIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher O.C.","family":"Bellamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2009.02.015_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: Patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"key":"10.1053\/j.ajkd.2009.02.015_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-75-3-369","article-title":"Survival with systemic sclerosis (scleroderma)","volume":"75","author":"Medsger","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2009.02.015_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0021-9681(73)90054-4","article-title":"Survival with scleroderma","volume":"26","author":"Medsger","year":"1973","journal-title":"J Chronic Dis"},{"key":"10.1053\/j.ajkd.2009.02.015_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/rheumatology\/ken307","article-title":"Renal manifestations of systemic sclerosis\u2014Clinical features and outcome assessment","volume":"47","author":"Denton","year":"2008","journal-title":"Rheumatology"},{"key":"10.1053\/j.ajkd.2009.02.015_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/37.1.15","article-title":"Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis","volume":"3","author":"Bunn","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.ajkd.2009.02.015_bib6","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2009.02.015_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: A French retrospective study of 50 patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2009.02.015_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2009.02.015_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1053\/j.ajkd.2009.02.015_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2005121256","article-title":"The endothelin system and its antagonism in chronic kidney disease","volume":"17","author":"Dhaun","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2009.02.015_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tips.2007.10.002","article-title":"Selective and mixed endothelin receptor antagonism in cardiovascular disease","volume":"28","author":"Dhaun","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1053\/j.ajkd.2009.02.015_bib12","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets\u2014A marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1053\/j.ajkd.2009.02.015_bib13","first-page":"831","article-title":"Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease","volume":"151","author":"Abraham","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2009.02.015_bib14","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2009.02.015_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.CIR.0000118499.69469.51","article-title":"Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: A comparison of selective and combined endothelin receptor blockade","volume":"109","author":"Goddard","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2009.02.015_bib18","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1097\/01.ASN.0000141313.84470.4B","article-title":"Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism","volume":"15","author":"Goddard","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2009.02.015_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jacc.2007.10.027","article-title":"Renin inhibition in hypertension","volume":"51","author":"Gradman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2009.02.015_bib20","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2009.02.015_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.rhu.0000173220.45196.75","article-title":"Resolution of hypertensive encephalopathy and scleroderma renal crisis with an angiotensin receptor blocker","volume":"11","author":"Rajendran","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1053\/j.ajkd.2009.02.015_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)61568-1","article-title":"Failure of losartan to control blood pressure in scleroderma renal crisis","volume":"349","author":"Caskey","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2009.02.015_bib23","first-page":"397","article-title":"Complications in the use of angiotensin receptor blockers in the treatment of scleroderma renal crisis","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638609005150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638609005150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:52:00Z","timestamp":1759456320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638609005150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0272638609005150"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2009.02.015","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelin Receptor Antagonism and Renin Inhibition as Treatment Options for Scleroderma Kidney","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2009.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}